Table 2 Intra- and postoperative clinical data.
Variable | Tria Ureteral Stent | Polaris Ultra Ureteral Stent | P-value |
|---|---|---|---|
(n = 41) | (n = 42) | ||
Surgical types | 0.697 | ||
Semi-rigid ureteroscopy | 8 (19.5) | 11 (26.2) | |
Flexible ureteroscopy | 31 (75.6) | 30 (71.4) | |
Combined | 2 (4.9) | 1 (2.4) | |
Ureteral access sheath use | 31 (75.6) | 31 (73.8) | 1.000 |
Stone-free status at the surgery | 34 (82.9) | 34 (81.0) | 1.000 |
Postoperative antibiotic use | 7 (17.1) | 8 (19.0) | 1.000 |
Duration, day, median (range) | 0.00 (0.00–3.00) | 0.00 (0.00–5.00) | 0.493 |
Postoperative complications | 2 (4.9) | 3 (7.1) | 1.000 |
Phone calls | 3 (7.5) | 1 (2.4) | 0.353 |
Emergency room visit | 3 (7.5) | 1 (2.4) | 0.353 |
Readmission | 1 (2.5) | 1 (2.4) | 1.000 |
Urine Analysis*, n (%) | |||
pH, median (IQR) | 6.00 (5.50–6.50) | 6.00 (6.00–6.50) | 0.291 |
Hematuria | 35 (85.4) | 36 (83.7) | 0.349 |
Pyuria | 24 (58.5) | 26 (63.4) | 0.500 |
Bacteriuria | 11 (26.8) | 10 (23.3) | 0.296 |
Crystalluria | 4 (9.8) | 4 (9.3) | 0.745 |
Hydronephrosis, n (%) | 0.672 | ||
Grade 0 | 34 (82.9) | 37 (90.2) | |
Grade 1 | 4 (9.8) | 3 (7.3) | |
Grade 2 | 2 (4.9) | 1 (2.4) | |
Missing | 1 (2.4) | 0 (0.0) | |
Duration of stent placement, day, median (IQR) | 18.0 (15.0–18.0) | 17.0 (15.0–18.0) | 0.318 |
